欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/7857/001
药品名称Bortezomib Glenmark 2.5 mg / mL Solution for Injection
活性成分
    • Bortezomib 2.5 mg/ml
剂型Solution for injection
上市许可持有人Glenmark Arzneimittel GmbH Industriestrasse 31 82194 Groebenzell Germany
参考成员国 - 产品名称Germany (DE)
Bortezomib Glenmark 2,5 mg/ml Injektionslösung
互认成员国 - 产品名称
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Denmark (DK)
      Bortezomib "Glenmark"
    • Netherlands (NL)
      Bortezomib Glenmark 2,5 mg/ml oplossing voor injectie
    • France (FR)
    • Spain (ES)
    • Italy (IT)
许可日期2024/10/21
最近更新日期2025/01/17
药物ATC编码
    • L01XG01 bortezomib
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Hybrid application (Art 10.3 Dir 2001/83/EC)
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase